Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease
This article is from
The Cancer Letter
archive.
Vol. 36 No. 1 | January 25, 2013
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
SWOG Plans Increase in Payments to Centers for Trial Accrual.
May 25, 2007
TCL Archive
Report Urges Stronger NCI Nutritional research
December 10, 1999
TCL Archive
The Cloning Story: How Dolly Made Page 1 And A Physicist Got Air Time
May 15, 1998
TCL Archive
St. Jude Offers Three Fellowships
May 3, 1985
TCL Archive
ODAC Votes for Marqibo Accelerated Approval
March 30, 2012
TCL Archive
Greenwald Lists Items Missing Because Not Enough Money Available
November 25, 1988
